Register | Log in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

eisei's sarcoma [29 articles]

Recent papers added to eisei's library classified by the tag sarcoma. You can also see everyone's sarcoma.
  • Prognostic role of cyclin D1 in retroperitoneal sarcomas.
    Cancer, Vol. 91, No. 2. (15 January 2001), pp. 428-434.
    by SH Kim, NH Cho, G Tallini, M Dudas, JJ Lewis, C Cordon-Cardo
    posted to cyclin-d1 sarcoma by eisei on 2008-04-11 11:59:22 as **
  • Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas.
    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 4, No. 10. (October 1998), pp. 2377-2382.
    by SH Kim, JJ Lewis, MF Brennan, JM Woodruff, M Dudas, C Cordon-Cardo
    posted to cyclin-d1 sarcoma by eisei on 2008-04-11 11:58:42 as **
  • Assessment of cyclin D1 overexpression as a prognostic factor in soft tissue sarcomas: role of laparoscopy and core needle biopsy.
    Surgical endoscopy, Vol. 19, No. 8. (August 2005), pp. 1120-1124.
    by M Musella, F Fazioli, S Lombardi, CI Servodio, C De Martino, V Iacono, F Cigala, R Jovino
    posted to cyclin-d1 sarcoma by eisei on 2008-04-11 11:58:06 as **
  • Nuclear beta-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma.
    Human pathology, Vol. 37, No. 6. (June 2006), pp. 689-697.
    by T Saito, Y Oda, H Yamamoto, K Kawaguchi, K Tanaka, S Matsuda, Y Iwamoto, M Tsuneyoshi
    posted to cyclin-d1 sarcoma by eisei on 2008-04-11 11:57:33 as **
  • Beta-catenin nuclear expression correlates with cyclin D1 expression in primary and metastatic synovial sarcoma: a tissue microarray study.
    Archives of pathology & laboratory medicine, Vol. 130, No. 6. (June 2006), pp. 792-798.
    by AE Horvai, MJ Kramer, R O'Donnell
    posted to cyclin-d1 sarcoma by eisei on 2008-04-11 11:57:09 as **
  • Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
    In vivo (Athens, Greece), Vol. 21, No. 5. (t 2007), pp. 729-737.
    by MM Bui, TK Bagui, DC Boulware, DG Letson, A Nasir, HE Kaiser, WJ Pledger, D Coppola
    posted to cyclin-d1 cyclins sarcoma by eisei on 2008-04-11 11:56:29 as **
  • Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells.
    Blood, Vol. 106, No. 9. (1 November 2005), pp. 3223-3226.
    by C Mayr, DM Kofler, H Büning, D Bund, M Hallek, CM Wendtner
    posted to cd40 cll sarcoma by eisei on 2008-04-11 11:55:46 as ** along with 1 person philill
  • CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes.
    Experimental hematology, Vol. 35, No. 6. (June 2007), pp. 920-930.
    by D Bund, C Mayr, DM Kofler, M Hallek, CM Wendtner
    posted to cd23 sarcoma by eisei on 2008-04-11 11:54:53 as **
  • Human Ly9 (CD229) as novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (B-CLL) recognized by autologous CD8+ T cells.
    Experimental hematology, Vol. 34, No. 7. (July 2006), pp. 860-869.
    by D Bund, C Mayr, DM Kofler, M Hallek, CM Wendtner
    posted to cd229 sarcoma by eisei on 2008-04-11 11:54:25 as **
  • Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma.
    Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, No. 35. (28 August 2007), pp. 13966-13971.
    by A Oldberg, S Kalamajski, AV Salnikov, L Stuhr, M Mörgelin, RK Reed, NE Heldin, K Rubin
    posted to sarcoma by eisei on 2008-04-11 11:53:56 as **
  • Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
    Molecular human reproduction, Vol. 11, No. 7. (July 2005), pp. 489-494.
    by E Levens, X Luo, L Ding, RS Williams, N Chegini
    posted to fibromodulin sarcoma by eisei on 2008-04-11 11:53:18 as **
  • Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.
    The Biochemical journal, Vol. 302 ( Pt 2) (1 September 1994), pp. 527-534.
    by A Hildebrand, M Romarís, LM Rasmussen, D Heinegård, DR Twardzik, WA Border, E Ruoslahti
    posted to fibromodulin sarcoma by eisei on 2008-04-11 11:52:35 as **
  • Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes.
    Blood, Vol. 105, No. 4. (15 February 2005), pp. 1566-1573.
    by C Mayr, D Bund, M Schlee, A Moosmann, DM Kofler, M Hallek, CM Wendtner
    posted to cll fibromodulin sarcoma by eisei on 2008-04-11 11:51:50 as ** along with 1 person philill
  • Markers of angiogenesis and clinical features in patients with sarcoma.
    Cancer, Vol. 109, No. 5. (1 March 2007), pp. 813-819.
    by S DuBois, G Demetri
    posted to sarcoma by eisei on 2008-04-11 11:51:08 as **
  • Targeting angiogenesis for the treatment of sarcoma.
    Current opinion in oncology, Vol. 18, No. 4. (July 2006), pp. 354-359.
    by L Balasubramanian, AM Evens
    posted to sarcoma by eisei on 2008-04-11 11:50:38 as **
  • Microvessel density does not predict outcome in high grade soft tissue sarcoma.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, Vol. 31, No. 10. (December 2005), pp. 1198-1205.
    by CC West, NJ Brown, DC Mangham, RJ Grimer, MW Reed
    posted to sarcoma by eisei on 2008-04-11 11:49:53 as **
  • Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    International journal of oncology, Vol. 27, No. 3. (September 2005), pp. 791-798.
    by M Onisto, ML Slongo, L Gregnanin, T Gastaldi, M Carli, A Rosolen
    posted to sarcoma by eisei on 2008-04-11 11:48:55 as **
  • Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 6, No. 2. (February 2000), pp. 572-577.
    by M Kaya, T Wada, T Akatsuka, S Kawaguchi, S Nagoya, M Shindoh, F Higashino, F Mezawa, F Okada, S Ishii
    posted to sarcoma by eisei on 2008-04-11 11:48:27 as **
  • Angiogenic profile of soft tissue sarcomas based on analysis of circulating factors and microarray gene expression.
    The Journal of surgical research, Vol. 135, No. 2. (October 2006), pp. 282-290.
    by SS Yoon, NH Segal, PJ Park, KY Detwiller, NT Fernando, SW Ryeom, MF Brennan, S Singer
    posted to sarcoma by eisei on 2008-04-11 11:47:43 as **
  • Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: a report from the Children's Oncology Group.
    Pediatric blood & cancer, Vol. 46, No. 3. (March 2006), pp. 329-338.
    by MC Blandford, FG Barr, JC Lynch, RL Randall, SJ Qualman, C Keller
    posted to sarcoma by eisei on 2008-04-11 11:47:20 as **
  • Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade.
    Annals of surgical oncology, Vol. 8, No. 3. (April 2001), pp. 260-267.
    by C Chao, T Al-Saleem, JJ Brooks, A Rogatko, WG Kraybill, B Eisenberg
    posted to sarcoma by eisei on 2008-04-11 11:46:44 as **
  • Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumors.
    Cancer research, Vol. 66, No. 3. (1 February 2006), pp. 1818-1823.
    by LT van den Broeke, CD Pendleton, C Mackall, LJ Helman, JA Berzofsky
    posted to sarcoma by eisei on 2008-04-11 11:46:16 as **
  • Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 23, No. 9. (20 March 2005), pp. 2004-2011.
    by PA Meyers, CL Schwartz, M Krailo, ES Kleinerman, D Betcher, ML Bernstein, E Conrad, W Ferguson, M Gebhardt, AM Goorin, MB Harris, J Healey, A Huvos, M Link, J Montebello, H Nadel, M Nieder, J Sato, G Siegal, M Weiner, R Wells, L Wold, R Womer, H Grier
    posted to sarcoma by eisei on 2008-04-11 11:45:01 as **
  • Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: planned interim analysis.
    Cancer biotherapy & radiopharmaceuticals, Vol. 19, No. 5. (October 2004), pp. 658-665.
    by R Dillman, S Selvan, P Schiltz, C Peterson, K Allen, C Depriest, E McClay, N Barth, P Sheehy, C de Leon, L Beutel
    posted to sarcoma by eisei on 2008-04-11 11:44:36 as **
  • Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics.
    Cancer immunity : a journal of the Academy of Cancer Immunology, Vol. 5 (1 February 2005)
    by NH Segal, NE Blachere, JA Guevara-Patiño, HF Gallardo, HY Shiu, A Viale, CR Antonescu, JD Wolchok, AN Houghton
    posted to sarcoma by eisei on 2008-04-11 11:43:46 as **
  • The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma.
    Cancer immunity : a journal of the Academy of Cancer Immunology, Vol. 4 (9 August 2004)
    by M Ayyoub, RN Taub, ML Keohan, M Hesdorffer, G Metthez, L Memeo, M Mansukhani, H Hibshoosh, CS Hesdorffer, D Valmori
    posted to ct sarcoma by eisei on 2008-04-11 11:41:32 as **
  • Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma.
    Journal of translational medicine, Vol. 3, No. 1. (12 January 2005)
    by Satoshi Kawaguchi, Takuro Wada, Kazunori Ida, Yuriko Sato, Satoshi Nagoya, Tomohide Tsukahara, Sigeharu Kimura, Hiroeki Sahara, Hideyuki Ikeda, Kumiko Shimozawa, Hiroko Asanuma, Toshihiko Torigoe, Hiroaki Hiraga, Takeshi Ishii, Shin-Ichiro I Tatezaki, Noriyuki Sato, Toshihiko Yamashita
    posted to syt-ssx sarcoma by eisei on 2008-04-11 11:40:52 as **
  • Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma.
    Journal of immunology (Baltimore, Md. : 1950), Vol. 169, No. 3. (1 August 2002), pp. 1611-1618.
    by Y Sato, Y Nabeta, T Tsukahara, Y Hirohashi, R Syunsui, A Maeda, H Sahara, H Ikeda, T Torigoe, S Ichimiya, T Wada, T Yamashita, H Hiraga, A Kawai, T Ishii, N Araki, A Myoui, S Matsumoto, T Umeda, S Ishii, S Kawaguchi, N Sato
    posted to sarcoma by eisei on 2008-04-11 11:39:51 as **
  • Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study.
    Medical and pediatric oncology, Vol. 38, No. 3. (March 2002), pp. 158-164.
    by R Dagher, LM Long, EJ Read, SF Leitman, CS Carter, M Tsokos, TJ Goletz, N Avila, JA Berzofsky, LJ Helman, CL Mackall
    posted to sarcoma by eisei on 2008-04-11 11:38:22 as **
    • Note: You may cite this page as: http://www.citeulike.org/user/eisei/tag/sarcoma

    RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.